Correction to: Sensitivity analysis of EGFR L861Q mutation to six tyrosine kinase inhibitors.

Liu, Chang; Wang, Zhenxing; Liu, Qian; Wu, Guangyao; Chu, Chunhong; Li, Lanxin; An, Lei; Duan, Shaofeng

Liu, Chang; Wang, Zhenxing; Liu, Qian; Wu, Guangyao; Chu, Chunhong; Li, Lanxin; An, Lei; Duan, Shaofeng.

Afiliação

Liu C; School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
Wang Z; School of Medicine, Henan University, Kaifeng, 475000, Henan, China.
Liu Q; Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, 475000, Henan, China.
Wu G; School of Medicine, Henan University, Kaifeng, 475000, Henan, China.
Chu C; Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, 475000, Henan, China.
Li L; School of Pharmacy, Henan University, Kaifeng, 475000, Henan, China.
An L; School of Medicine, Henan University, Kaifeng, 475000, Henan, China.
Duan S; Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, 475000, Henan, China.

Clin Transl Oncol ; 26(2): 557, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37982971

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google